Publication: Patterns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinations.
Loading...
Identifiers
ISSN: 2213-0489
Full text access: http://hdl.handle.net/20.500.13003/17426
SCOPUS: 2-s2.0-84942514302
Publication date
Advisors
Journal Title
Journal ISSN
Volume Title
Publishers
Abstract
We report the characteristics of relapse, treatment response, and outcomes of 145 elderly patients with multiple myeloma in first relapse after front-line treatment with VMP or VTP. Reappearance of CRAB symptoms (113 patients) and more aggressive forms of disease (32 patients) were the most common patterns of relapse. After second-line therapy, 75 (51.7%) patients achieved at partial response and 16 (11%) complete response (CR). Overall survival was longer among patients receiving VMP as front-line induction (21.4 vs. 14.4 months, P=0.037), in patients achieving CR (28.3 vs. 14.8 months; P=0.04), and in patients without aggressive relapse (28.6 vs. 7.6 months; P=0.0007).
Description
MeSH Terms
DeCS Terms
Bibliographic citation
Lopez A, Mateos MV, Oriol A, Valero M, Martinez J, Lorenzo JI, et al. Patterns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinations.. Leuk Res Rep. 2015;4(2):64-9.





